Search This Blog

Friday 20 January 2023

In News

In News


Hindustan Unilever: The FMCG major clocked an 11.7 percent year-on-year growth in standalone profit at Rs 2,505 crore for the quarter ended December FY23, backed by revenue from operations that grew by 16.3 percent to Rs 15,228 crore for the quarter with domestic volume growth at 5 percent, and higher other income. Profitability was impacted by an exceptional loss of Rs 102 crore for the quarter against Rs 66 crore in the year-ago period. At the operating level, EBITDA increased 7.9 percent to Rs 3,537 crore but the margin fell 180 bps YoY to 23.2 percent in Q3FY23 impacted by higher raw material costs. Royalty fees paid by the company to Unilever Plc have been increased to 3.45 percent from 2.65 percent of turnover.


PVR: The multiplex chain operator has reported a consolidated profit of Rs 16.1 crore for the quarter ended December FY23, against a loss of Rs 10.2 crore in the same period last year. Consolidated revenue for the quarter at Rs 941 crore increased by 53 percent, with the movie exhibition business growing 37 percent and others (including movie production & distribution) by 23.5 percent YoY. EBITDA in Q3FY23 grew by 75 percent to Rs 288.8 crore and the margin expanded by nearly 4 percentage points to 30.7 percent for the quarter YoY.


Sun Pharmaceutical Industries: The pharma company is going to acquire Concert Pharmaceuticals for $576 million or $8 per share. Concert stockholders will also receive a non-tradeable contingent value right (CVR) entitling holders to receive up to an additional $3.50 per share on deuruxolitinib achieving certain net sales milestones within specified periods. Concert is a late-stage biotechnology company, developing deuruxolitinib, an oral inhibitor of Janus kinases JAK1 and JAK2 for the treatment of alopecia areata, an autoimmune dermatological disease.


Can Fin Homes: The company has reported a 31 percent year-on-year growth in profit at Rs 151.5 crore for quarter ended December FY23, supported by lower provisions. Net interest income for the quarter at Rs 251.71 crore grew by 22.23 percent YoY. Asset quality improved with gross non-performing assets (NPA) improving by 2 bps QoQ to 0.60 percent and net NPA falling 5 bps to 0.30 percent in Q3FY23.


Hindustan Zinc: The company has reported a 20.2 percent year-on-year decline in consolidated profit at Rs 2,156 crore for quarter ended December FY23, impacted by lower revenue, operating income and higher power & fuel cost. Revenue fell 1.6 percent YoY to Rs 7,866 crore for the quarter. EBITDA fell 15.2 percent to Rs 3,707 crore and margin dropped 760 bps to 47.1 percent compared to year-ago period. The company will pay an interim dividend of Rs 13 per share for FY23 and will buy international zinc assets from Vedanta by subscribing to the shares of THL Zinc for $2,981 million.


L&T Technology Services: The engineering services company has reported a 7.5 percent sequential growth in profit at Rs 303.6 crore for December FY23 quarter, with revenue rising 2.7 percent to Rs 2,048.6 crore and revenue in dollar terms increasing 0.4 percent to $248 million for the quarter. At the operating level, EBIT climbed 6.3 percent sequentially to Rs 382.9 crore and margin expanded 60 bps to 18.7 percent for the quarter. Also the company received a multi-year contract from Airbus for providing advanced engineering capabilities and digital manufacturing services.


Tata Consultancy Services: Canadian business jet manufacturer, Bombardier selected TCS as its strategic IT partner, to accelerate its digital transformation & drive innovation.

No comments:

Post a Comment

SLL -- Short Term

SHORT TERM CALL Buy Suven Life Sciences Cmp 63 SL Below 55 Tgt 66 / 69 / 72 / 75 / 78++ In Coming Days..